Losing Muscle on a GLP-1: How to Protect It

TL;DR: When you lose weight on a GLP-1 medication, some of what comes off is muscle as well as fat. In the semaglutide STEP 1 body-composition substudy, about 39% of the total weight lost was lean (fat-free) mass, a ratio close to what happens with most rapid weight loss. The reassuring part is that total fat fell faster than lean, so average body-fat percentage improved. The part to plan for is that muscle is hard to rebuild, more so with age, and losing it works against the metabolic health you are trying to gain. The fix has three parts: eating enough protein, training against resistance, and tracking your body composition rather than the scale alone.

GLP-1 medications are among the most useful tools we have for weight and metabolic health. They also come with a trade-off worth taking seriously: when the weight comes off quickly, a share of it is muscle. This page lays out how much, why it matters for the years ahead, and the specific plan that keeps most of your muscle while the fat leaves.

How much muscle do you lose on a GLP-1?

When your body loses weight, it rarely comes off as pure fat. Some fat-free mass, which includes muscle along with water and other tissue, comes off too. This is true of dieting, bariatric surgery, and GLP-1 medications alike.

The clearest picture comes from the trials. In the STEP 1 body-composition substudy of semaglutide, participants lost a large amount of weight, and roughly 39% of that loss was lean mass while the rest was fat.¹ Because fat fell faster than lean, average body-fat percentage went down, so on paper body composition improved. Tirzepatide showed a similar pattern in its obesity program, with body composition tilting toward a lower fat share.² So the ratio itself is close to ordinary weight loss. The muscle loss is not a strange effect of the drug; it is what rapid weight loss does.

The cleanest proof of that came from the tirzepatide body-composition substudy, where the lifestyle-only comparison group lost lean mass in nearly the same proportion as the drug group, close to a quarter of the weight lost in each.⁶ A 2024 review made the same point directly: fat-free-mass loss on these medications is expected weight-loss physiology rather than a drug-specific toxicity.⁷ That reframe matters, because it points the solution away from the drug and toward the support that protects muscle during any rapid weight loss.

The reason I still flag it is that averages hide the people who get hurt. Someone who starts with modest muscle, eats little protein, and does no resistance training can lose a lot of muscle in absolute terms, ending up lighter but weaker.

Why does muscle loss matter more than the scale?

Muscle does far more than move you. It is the largest site where your body disposes of blood sugar, a major driver of resting metabolism, and one of the strongest predictors of how well you age. Higher muscle mass tracks with lower mortality in older adults, and low muscle tracks with frailty, falls, and losing independence.⁵

That is the catch with losing muscle to get lighter. You can improve the number on the scale while eroding the tissue that keeps your metabolism healthy and your body capable. For the prevention-minded person who wants to be strong at 80, trading muscle for weight loss is the opposite of the goal. Muscle is also slow and hard to rebuild, and that gets harder with each decade, so muscle lost in a fast weight-loss phase may not come back easily.

How do you keep your muscle while losing fat on a GLP-1?

This is the part you control, and it makes more difference than the brand or the dose. Three levers do most of the work.

Eat enough protein. Protein is the raw material your body uses to hold onto muscle during weight loss. Higher-protein diets preserve more fat-free mass while people lose weight than standard-protein diets do.³ The challenge on a GLP-1 is that the medication quiets appetite, so many people drift into eating too little of everything, protein included. A target of about 1.6 to 2.2 grams per kilogram of goal body weight, spread across the day as roughly 25 to 40 grams of high-quality protein per meal, gives muscle what it needs. In practice that often means anchoring each meal around a protein source first. Older adults should aim toward the higher end, because aging muscle needs more protein per meal to mount the same response, a pattern called anabolic resistance, and guideline groups already recommend higher protein paired with resistance training in that age range.⁸

Train against resistance. Diet alone loses more muscle than diet plus exercise,⁴ and resistance training is the form best suited to defend muscle while you lose fat. Two to four sessions a week that work the major muscle groups, at a challenging effort, signal your body to keep the muscle it has. Walking and cardio are good for other reasons, but lifting is what defends muscle. Our full case for this is in muscle is the organ of longevity.

Lose at a sustainable pace, at the right dose. A slower, steadier rate of loss gives muscle a better chance to keep up, which is one argument for finding the lowest effective dose rather than climbing to the maximum by default. The dose should match your goal rather than a fixed schedule.

Can ketones help protect muscle during GLP-1 weight loss?

This is an early and interesting question, and it sits a full tier below protein and training in the evidence. In 2026, a research group published a preclinical study asking whether a ketone ester, given alongside semaglutide, could protect muscle without blunting fat loss. In diet-induced-obese mice treated for three weeks, the animals on semaglutide alone lost a substantial amount of lean mass, while those that also received the ketone ester lost roughly two-thirds less, with no difference in fat loss between the two groups.⁹ A companion paper from the same group reported a parallel protective effect on heart muscle.

The proposed mechanism is plausible and predates the GLP-1 era. Beta-hydroxybutyrate, the main ketone body, is an efficient fuel that yields more energy per unit of oxygen with less oxidative stress, and it carries a direct protein-sparing effect. In a classic human infusion study, raising blood ketones cut whole-body protein breakdown by roughly a third and modestly raised muscle protein synthesis.¹⁰ During a calorie deficit, when muscle is under pressure, that is the kind of signal that tells the body to stop breaking muscle down for fuel.

The caveats deserve to be stated plainly, because this is the kind of finding that gets over-extrapolated. It is a mouse study, at a ketone dose no human protocol would match, over three weeks, and it measured whole-body lean tissue rather than dissected muscle. No human trial has yet shown that exogenous ketones preserve muscle across a genuine, multi-month weight-loss course, and long-term ketosis carries its own downsides, so at most this would be a deliberate, time-limited tool for the steepest stretch of weight loss rather than a daily habit. For now it is a reason to watch the space closely rather than a reason to add another supplement. The foundation is still protein and resistance training.

How should you track muscle instead of guessing?

The scale cannot tell muscle from fat, so it is the wrong tool for this job. A few better signals:

• A DEXA scan before starting and again a few months in gives you the measured split of fat and lean mass, so you know whether your plan is working.
• Grip strength is a simple, repeatable proxy for whole-body strength that you can recheck over time.
• Strength in the gym. If the weights you handle are holding or rising while you lose fat, you are defending muscle. If they are dropping fast, that is a signal to add protein, train more, or slow the pace.

"The single biggest thing that decides how a patient does on a GLP-1 is whether they protect their muscle while the weight comes off. I have seen people lose thirty pounds and come out metabolically stronger, and I have seen people lose the same thirty and come out weaker, because one plan had protein and lifting in it and the other did not. The medication takes the weight off. Your job, and mine, is to make sure as much of it as possible is fat. That is the whole game."

Related at Fishtown Medicine

• Muscle Is the Organ of Longevity - why protecting muscle is the whole point
• GLP-1 Microdosing: What It Is and Whether It's Worth It - finding the lowest effective dose
• GLP-1 vs Bariatric Surgery - how the muscle question plays out on both paths
• DEXA Scan in Philadelphia - measuring fat and lean mass directly
• Grip Strength: A Longevity Biomarker - a simple way to track strength over time

Scientific References

1. Wilding JPH, Batterham RL, Calanna S, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine. 2021;384(11):989-1002.
2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine. 2022;387(3):205-216.
3. Wycherley TP, Moran LJ, Clifton PM, et al. "Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials." American Journal of Clinical Nutrition. 2012;96(6):1281-1298.
4. Weinheimer EM, Sands LP, Campbell WW. "A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults." Nutrition Reviews. 2010;68(7):375-388.
5. Srikanthan P, Karlamangla AS. "Muscle mass index as a predictor of longevity in older adults." American Journal of Medicine. 2014;127(6):547-553.
6. Look M, Dunn JP, Kushner RF, et al. "Body composition changes during weight reduction with tirzepatide (SURMOUNT-1)." Diabetes, Obesity and Metabolism. 2025.
7. Tinsley GM, Heymsfield SB. "Fundamental body composition principles provide context for fat-free and skeletal muscle loss with GLP-1 RA treatments." Journal of the Endocrine Society. 2024.
8. Bauer J, Biolo G, Cederholm T, et al. "Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group." Journal of the American Medical Directors Association. 2013;14(8):542-559.
9. Abuetabh Y, Schmidt MA, et al.; Dyck JRB. "Semaglutide-induced loss of skeletal muscle mass is blunted by co-administration of ketone esters." JCI Insight. 2026.
10. Nair KS, Welle SL, Halliday D, Campbell RG. "Effect of beta-hydroxybutyrate on whole-body leucine kinetics and muscle protein synthesis in humans." Journal of Clinical Investigation. 1988;82(1):198-205.